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Maria Gordon Buse, MD, is a product of
wartime Europe. She completed her
professional education in four languages
on three continents and continues a
nearly 60-year career as an investigator,
educator, and practicing endocrinologist.
This brief reprisal is written collabora-
tively by her biological offspring and in-
tellectual progeny, an appropriate reflection
of a career where family and work were
joyfully intertwined in an irresolvable way.
THE EARLY YEARS
Maria Gordon Buse was born Maria
Felice Gordon in Budapest, Hungary. Her
mother, Elizabeth Szana, was the “great
beauty” of her social circle, and her fa-
ther, Geza, was an earnest accountant
who tried his hand at several failed
entrepreneurial activities before buying
a café on the Danube near the sym-
phony hall. In that venture, Elizabeth’s
charms and Geza’s practical business
acumen resulted in a successful enter-
prise that was a gathering place for stu-
dents, artists, and the middle class in
Budapest. Maria was raised speaking
German in the home and only learned
Hungarian when she went to school.
She mastered French as a third lan-
guage in middle school. Maria loved
poetry, literature, theater, art, music,
walking in the woods during trips to
the nearby mountains, and ice skating.
She aspired to become a poet and a jour-
nalist. She was 16 in 1943 when German
troops occupied Budapest. Through the
intercession of friends, Maria and her
mother took refuge in a cloister, and
her father, in a monastery. Her mother
was fearless about going out into the
city through bombings and gunfire,
leveraging her many social connections
to find food and supplies. Maria never
takes for granted how lucky she and her
family were to survive. As the Allies ap-
proached to “liberate” Hungary, she re-
calls laughing at the sky, seeing the
showering bombs as symbolic of their
impending freedom and the justice that
the Axis powers would face. She wel-
comed her Russian liberators in that
spirit, only to discover that they were
as cruel as the Nazis. She was briefly
interred in a labor camp. Her childhood
left her with an absolute intolerance of
any hint of fascism or prejudice and a
drive to take advantage of any opportu-
nity for enjoyment of the simple plea-
sures that she had been exposed to as a
childdlearning, good food, beauty in all
its forms, and nature. Maria says, “I really
wanted to be a writer. But my mother
and everyone else explained to me that
I would never make a living. And I had
always been interested in science and
medicine. I sort of thought it might be
fun to be a doctor.” Fascination and fun
with science has been the hallmark of her
career.
At the war’s end in 1945, her parents
divorced. When her mother remarried a
childhood sweetheart, Bartholomew
Richter, she gained a stepbrother, Paul,
who would become an oncologist in
Atlanta.
Maria Gordon Buse, MD, in front of a rack of
Langendorff baths used to perfuse isolated beat-
ing rat hearts circa 1972. These studies resulted
in important findings about cardiac fuel me-
tabolism and changes induced by epinephrine,
glucagon, and nutritional states with continuing
relevance to diabetes treatments today (cour-
tesy of the Waring Historical Library, MUSC,
Charleston, SC).
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Maria started medical school at the
Pázmány Péter University School of
Medicine in Budapest. However, as it
was essentially destroyed, she left to
continue her studies at the University
of Basel from 1946 to 1948. As a for-
eigner in Switzerland, she knew that
she could not be licensed to practice
medicine there and immigrated to Ar-
gentina with the assistance of an uncle.
She had to learn Spanish adequately to
pass the exams required to enter the
University of Buenos Aires as an ad-
vanced medical student without losing
the 2 years of credit she had completed
in Europe. Her mother, stepfather, and
Paul joined her shortly afterward. She
received her MD in 1952. After house-
staff training in the Hospital Rivadavia,
she was able to do research in Nobel Lau-
reate in Physiology Bernardo Houssay’s
institute with Drs. Houssay, Eduardo
Braun-Menéndez, and Carlos Rapela.
Her work on the seasonal variation in
catecholamine production in the toad
resulted in the faculty prize for best the-
sis in 1956. When asked “Why toads?”
she replied, “Toads are cheap. You could
catch them in the courtyards of his in-
stitute.” Frugality and opportunism in re-
search would become a recurring theme
in her career.
The prize allowed her to travel to Phil-
adelphia to continue her studies with
Dr. Francis D.W. Lukens at the George
S. Cox Medical Research Institute at the
University of Pennsylvania. Dr. Lukens
sent a shy endocrine fellow from South
Carolina named John Buse to pick her up
at the airport. Thus began an almost
50-year partnership in research, teach-
ing, clinical medicine, and child-rearing.
They published their first article to-
gether on the action of sulfonylureas
in animal models in Diabetes in 1957.
They were married in August 1957 and
borrowed a car and honeymooned on
the Blue Ridge Parkway on the drive to
Charleston, SC, where they both joined
the faculty of the then-named Medical
College of South Carolina, now called
theMedical University of South Carolina
(MUSC).
“Dr. Maria” and “Dr. John,” as they
came to be known, were the first trained
endocrinologists in the state. Maria was
appointed in the Departments of Medi-
cine and Biochemistry. The couple
shared an office suite and laboratory
focused on metabolism research and
worked in the same clinic and hospital
wards. InMaria’s first fewmonths at the
new job, the hospital recognized the
need to establish a unit to explore and
harness the diagnostic and therapeutic
power of radioisotopes in medicine.
Given that Maria had completed a
1-week course on the subject at Woods
Hole while a fellow, she was asked to
establish the Nuclear Medicine Labora-
tory. She led the unit from an endocrine-
oriented hospital service to a full section
of Nuclear Medicine in the Department
of Radiology and participated in its prac-
tice for nearly 50 years.
Their first child, John, future Presi-
dent, Medicine & Science of the Ameri-
can Diabetes Association, was born in
1958. After the Hungarian Revolution,
Maria’s father Geza immigrated to
Charleston, became a successful print
framer and art dealer, settled into a
nearby apartment, and shared dinner
with the family every day until he died
in 1976. Maria settled into a life balanc-
ing family life, raising three children,
medicine, and science. She read to the
children or helped with homework every
night, returning to the dining room table
to her slide rule and piles of data and
journal reprints to write manuscripts
and grants. Having been raised in a land-
locked country, she loved the ocean and
spent almost every weekend and a
month in the summer with her family
at the Isle of Palms, where John bought
her a small beach front cottage while
they were still renting an apartment in
town.
THE 1960S
In the early years in Charleston, Maria
and John shared equally in the clinical
and laboratory duties. Their initial re-
search involved organ culture explor-
ing the effects of denervation on
glucose uptake and insulin action in
muscle. Together, with John as principal
investigator, they wrote a grant applica-
tion to the National Institutes of Health
(NIH) entitled “Factors that modify insu-
lin action.” On first review they were un-
successful, with the critique including
the stinging rebuke that they wrote “as
if paid by the word instead of by the
thought.” On resubmission in 1960,
they received the first NIH grant awarded
to the state of South Carolina, which con-
tinued through 10 competitive renewals
through 2014. She rather humbly sug-
gested that having one of the longest
continuous grants at the NIH was due
to coming up with a grant name that
could accommodate the evolving focus
of the grant.
For Maria and John, the constant mix-
ture of marriage, scientific and medical
partnership, child-rearing, training, and
research mentorship blurred the dis-
tinctions between family and work.
Maria did not drive and always thought
that taxicabs were an extravagance. So,
they bought a house just two blocks
from the medical school in 1962, where
for over 50 years there was an endless
stream of trainees and colleagues that
were an accepted part of the family even
among the three children (John Buse,
MD, PhD; Paul Buse, MD; and Elizabeth
Buse King, MBA).
In 1960, based in part on Maria’s
Hungarian accent as an impediment to
patient care and John’s lesser interest in
writing manuscripts and grants, they be-
gan to differentiate. Maria took more
of the lead in the laboratory aspects of
their collaboration, while John contin-
ued work as one of the most respected
Top: Maria Gordon Buse, MD, and John F. Buse Jr.,
MD,circa1970,standinginfrontoftheBeckmanmodel
121 amino acid analyzer that was almost like their
fourth child, only more expensive, fussy, and ill-
behaved. Bottom: Maria Gordon Buse, MD, circa
2003 (both courtesy of theWaringHistorical Library,
MUSC, Charleston, SC).
clinicians in the medical school. This
partnership was a boon to the multiple
clinician-scientists who worked with
Maria. All of them can remember sit-
ting in the laboratory when John would
drop by and suggest that they put on a
white coat (mostly to cover the rather
informal laboratory attire) and accom-
pany John to thewards, whichwere just
down the hall from the laboratory.
There, John would demonstrate some
interesting physical finding in his inim-
itable manner, such as xanthomatous
eruptions from “the greasy blood.” This
manner delighted the patients, who
were quickly put at ease, and allowed
the students to learn. Indeed, in an era
before institutional review boards, many
times Maria would instruct that blood
be obtained from interesting patients to
do additional studies.
Maria transferred her experience
from using isotopes in radioimmuno-
assays, clinical thyroid imaging, and
treatment to their use in translational
studies, becoming the first person to
use radioisotopes at MUSC in research.
In a landmark article published in the
Journal of Clinical Investigation in 1962
(1), she administered 131I-insulin to
women (after first treating with potas-
sium iodine) prior to birth and deter-
mined that little, if any, insulin crossed
the placenta. This showed that any in-
crease in size of the fetus in a mother
with diabetes was due to increased pro-
duction of insulin by the fetus and not
due to transplacental insulin transfer.
When talking about this study, she would
point out that this was her first use of
a computer in her studies. Accessed
through The Military College of South
Carolina (The Citadel), she used a Donner
analog computer for curve fitting the ob-
served degradation of insulin. It was likely
the first “portable” computer used at
MUSC.
In addition to her work with radioiso-
topes, Maria began studies that would
occupya significant portionofher research
career, the effect of insulin and branched-
chain amino acids (BCAAs) on skeletal
muscle metabolism (2,3). Although it
was known that exercise could have a
profound effect on insulin sensitivity,
the effect of immobility on insulin action
had not been studied until 1959, when
Maria, working with John in some of their
first studies in South Carolina, began a
series of experiments that showed that
denervation of diaphragms or hind limbs
of rats resulted in a rapid and marked
decrease in insulin responsiveness to
glucose uptake and to amino acid uptake
and protein synthesis.
The initial report (2), published in 1959,
was one of the first ever to assess insulin
binding to whole-tissue mammalian tis-
sue. Using 131I-insulin, Maria showed
that there was no significant difference
in insulin binding between innervated
and denervated hemidiaphragms when
assessed both in vitro and in vivo, dem-
onstrating the first “postreceptor” defect
in insulin action, a topic that she would
continue to investigate throughout her
career. These were heroic experiments
performed in the laboratory by injecting
up to 10 mCi of 131I-insulin intravenously
into rats, their cages shielded by lead
bricks. These rather crude studies have
stood the test of time and have been con-
firmed by multiple researchers using
more sophisticated techniques. The initial
MariaGordonBuse,MD, and a portion of her extended family of colleagues, trainees, and progeny in AngkorWat, Cambodia, July 2007. Left to right: Anne
Peters, Mark Harmel, Maggie Burant, Charles Burant, Maria Gordon Buse, Linda Cann, Richard Kahn, Stephanie Kahn, and John Buse (courtesy of Mark
Harmel).
Maria Gordon Buse, MD, circa 2012, engaged in
conversation on the porch of her beach house
(courtesy of Katherine Buse).
studies investigating the effects of dener-
vation were done in hemidiaphragms
following phrenectomy. Over the years,
hundreds of phrenectomies and dia-
phragm isolations were performed in
the laboratory and nearly every proce-
dure was done personally by Maria. She
was, and continues to be, proud of her
surgical skills and insisted that she was
the only one skilled enough to perform
phrenectomy and diaphragm isolation
properly, thoughmore than one graduate
student and postdoc suspected that she
simply wanted to continue to participate
in the “hands-on” portion of the studies
and, importantly, participate in the cama-
raderie that was part of the enjoyment of
working in the Buse laboratory.
THE 1970S
In studying the effect of insulin in skel-
etal muscle, Maria’s studies found that
fatty acids had a unique effect to in-
crease the oxidation of BCAA in muscle
and heart with a pronounced effect on
leucine oxidation as opposed to valine
and isoleucine. The observation that
conditions that are associated with in-
creased levels of fatty acids, such as un-
controlled diabetes or insulin resistance,
were associated with increased catabo-
lism of BCAA and muscle wasting led to
another seminal article in the Journal of
Clinical Investigation (4) that demon-
strated that leucine, but no other amino
acid, stimulated the uptake and incorpo-
ration of 14C-lysine into hemidiaphragm
proteins. This effect was modulated min-
imally by insulin but could be affected by
fatty acids, diabetes status, and denerva-
tion of muscle. In addition to stimulating
protein translation initiation, blocking
transcription or translation also showed
that leucine had the ability to simulta-
neously reduce protein breakdown. Over
the past three decades, it has become
clear that much of the effect of leucine
to alter metabolism is via the activation
of the enzyme mammalian target of rapa-
mycin (mTOR), an enzyme complex that
is a primary sensor of nutrient status, a pri-
mary mediator in the regulation of skeletal
muscle protein dynamics (5).
THE 1980S AND 1990S
During this time, studies in the labora-
tory centered on the continued explora-
tion of insulin action in denervated
skeletal muscle as well as defining
BCAA metabolism. Some of the first
studies ever to examine the activation
of the insulin receptor kinase in intact
animals (6) showed that the rapid de-
cline in insulin-stimulated glucose up-
take was not due to alterations in the
autophosphorylation or the kinase ac-
tivity of the insulin receptor, but defined
the signaling disruption as a postrecep-
tor defect, subsequently found to be due
to impaired insulin receptor substrate-1–
mediated increase in phosphoinositide
3-kinase activation (7). The regulation of
BCAAmetabolism continued to be stud-
ied with detailed examination of the
rate-limiting step in BCAA metabolism,
the multisubunit ketoacid dehydroge-
nase complex, which shares several
subunits with the pyruvate dehydroge-
nase enzyme. Detailed studies showed
regulation in the muscle, liver, and
other tissues by fasting/refeeding,
high-fat diets, insulinopenic diabetes,
glucocorticoids, and endotoxins, among
others. The data showed an intimate
relationship between BCAAmetabolism
and the control of protein synthesis and
degradation in tissues under pathologi-
cal states. These studies helped clarify
the beneficial effects of both BCAA and
their ketoacids in disease states (8).
In the 1990s, Maria’s research inter-
ests also evolved to investigations
around the way in which glucose, amino
acids, and other nutrients modified in-
sulin signaling, including posttransla-
tional modification of insulin receptors
and their downstream targets and alter-
ation in glucose transporter function
glucosamines (9,10). These studies
showed that modification of serine res-
idues by glucosamine could have a sig-
nificant effect on the signaling in cells
and tissues.
THE 21ST CENTURY
The focus of the Buse laboratory in-
creasingly focused on the regulation of
insulin receptor signaling and the poten-
tial for posttranslational changes in sig-
naling molecules in insulin-resistant
states. Maria identified a novel muscle-
specific variant of the glutamine:fructose-
6-phosphate amidotransferase-1 (GFAT-1),
the rate-limiting enzyme of the hexos-
amine synthesis pathway, which alters
enzymatic activity and may predispose
muscle to insulin resistance inhigh-glucose
conditions (11). She described the sites
of O-linked b-N-acetylglucosamine mod-
ification in a number of proteins and
showed that these modifications al-
tered their function, likely part of the
broad array of changes in the insulin-
resistant, diabetic state that is part of
the alteration in insulin signaling (12).
Thus, she continued a line of research
that stretches back to before the vast
majority of her trainees were born.
Clinically, her career came full circle.
After retiring from radiology, based on
her vast experience as a “dot spotter”
(John’s characterization of her work in
nuclear medicine), she returned to the
endocrine division to precept fellows
and students. When her funding from
the NIH ran out in January 2014, her
family encouraged her to use funds at
her disposal to continue with her pas-
sion for research and teaching. She
refused, insulted at the suggestion, re-
lating that if her ideas were not good
enough for the NIH, it was time to call
it quits. Her last article (13), with first
author Katherine (Katy) Robinson (who
worked with Maria for over 28 years),
described the activity of Go-6976, an in-
hibitor of “conventional” protein kinase
C (PKC) isoforms PKCa and PKCb, and
the mTOR inhibitor rapamycin to allevi-
ate insulin resistance induced in 3T3-L1
adipocytes by incubation in high-glucose
media. They found that Go-6976 did in-
duce a partial alleviation of insulin re-
sistance, but it likely was working
through alterations in mTOR signaling,
not PKC-mediated pathways. It seems
fitting that after 50 years of studying
BCAA effects, the molecular entity that
mediates the effect of BCAAs would
be the focus of Maria’s latest contribu-
tion to the literature. There may be still
one more future article based on the
continuing efforts of her last fellow,
Dr. Lauren Ball, who continues the work
in Charleston.
SUMMARY
In a career that spanned nearly 60 years,
Maria believed that being able to do sci-
ence and to share in the lives of trainees
was a sacred gift. At the same time, she
was selfless in her devotion to the tasks
of an academic clinician and selfish in
that she was doing what she loved. Her
pioneering efforts in South Carolina as
an investigator, clinician, and faculty
member were recognized by numerous
awards from the state and her institution.
Hermost prized recognitionwas receiving
the American Diabetes Association’s
Albert Renold Award in 2003 because it
carried the name of a respected friend
and colleague and because it recognized
her for her accomplishment as a mentor,
which she saw as the highest possible
calling in academia.
The freedom that Maria allowed the
trainees in the laboratory encouraged
risk-taking, provided it was based on
some reasonable hypothesisdthe “idiot
experiments.” Maria says, “Only an idiot
would try it, but sometimes idiots are
geniuses in disguise.”Maria was a fixture
in the laboratory, almost never pushing
for studies to be completed, but rather
discussing, critiquing, and encouraging
discovery. She instilled an infectious de-
sire to find out the answer. As often hap-
pened, the first results of an experiment
would be obtained and a grand theory
would be based on the initial results. As
often as not, the theory would be de-
stroyed by the subsequent findings, but
the thought experiments were consid-
ered valuable by the trainees as a way
to think about the project, the techniques,
and the holes in the theory. Few minded
these sometimes rambling, but always en-
tertaining, discussions as they always knew
more at the end than when they started,
mostly because Maria had an amazing
mastery of the literature. She got this by
reading voraciously and encouraged train-
ees to do the same, often arranging for a
couple hours of library time (before the
advent of the Internet). She instilled a
sense of inquiry for not only science but
also politics, cultures, and personal rela-
tionships. Likely because she had fearlessly
traveled all her life to virtually every corner
of the globe, Maria encouraged and sup-
ported her trainees to travel abroad for
meetings for the science and perhaps
more for the cultural exposure that it pro-
vided. She traveled abroad almost every
year, usually on the pretext of a meeting
but extending the trip for a week or more.
The Buse laboratory was always the
“place to be,” with the numerous medical
students, graduate students, postdocs, and
MD/PhD students, the latter of which
seemed in particular to gravitate toMaria’s
laboratory. Maria was instrumental in the
creation of the Medical Scientist Training
Program at MUSC, and she had a hand in
training about half of the first groups of
students in the nascent program.
The people in her laboratory learned
to work hard and to play hard. They en-
joyed the famous fruit daiquiris on Fri-
day afternoons in the conference room,
and the party often migrated to Maria
and John’s home (two blocks away) for a
cookout and “a touch of the red,” the
latter a wonderful wine that lubricated
lively discussions of science, politics,
travel, inevitable reminiscences, and
even an occasional robust recital by
Maria of the Hungarian national anthem.
The care and nurturing both in and out-
side of the laboratory gave rise to the
feeling that one was truly part of a fam-
ily, with John and Maria at the head of
the table. This tradition continued after
her beloved John died in 2001. She trav-
els very little these days, but enjoys read-
ing, movies, and visits with family or
colleagues, technicians, or trainees who
come by to take her for dinner or amovie.
Even after a long, successful, and enjoy-
able career, Maria continues to be a
sourceof friendship, comfort, andwisdom
to her biological and adopted family.
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